4basebio UK Societas AI Stock Analysis
4basebio UK Societas (88Q) AI Stock Analysis
4basebio UK Societas
(XETRA:88Q)
No summary available
4basebio UK Societas (88Q) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 81.30M
- Dividend Yield
- ―
- Average Volume (3M)
- 409
- Price to Earnings (P/E)
- -4.5
- Beta (1Y)
- 0.23
- Revenue Growth
- -57.54%
- EPS Growth
- -12.93%
- Country
- Germany
- Employees
- 140
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
4basebio UK Societas Business Overview & Revenue Model
Company Description
4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutio...
4basebio UK Societas Peers Comparison
Overall Rating
GB:BVXP89Outperform
GB:APTA46Neutral
GB:AVCT40Underperform
GB:FAB40Underperform
GB:OBD40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 89Outperform | GBP 102.93M | 13.59 | 67.81% | 7.61% | -1.10% | 0.32% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 46Neutral | GBP 13.01M | -12.17 | -46.61% | ― | 28.35% | 57.14% | |
| 40Underperform | GBP 299.86M | -6.47 | -1293.07% | ― | ― | ― | |
| 40Underperform | GBP 5.32M | -4.29 | -97.87% | ― | 7.38% | 44.13% | |
| 40Underperform | GBP 16.13M | -0.29 | -451.74% | ― | 33.37% | 86.41% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:88Q | 4basebio UK Societas | 5.85 | -2.20 | -27.33% | |
| GB:AVCT | Avacta Group plc | 59.00 | -22.00 | -27.16% | |
| GB:BVXP | Bioventix plc | 1970.00 | -17.97 | -0.90% | |
| GB:OBD | Oxford BioDynamics | 0.12 | -0.17 | -58.93% | |
| GB:FAB | Fusion Antibodies Plc | 4.25 | -8.00 | -65.31% | |
| GB:APTA | Aptamer Group Plc | 0.36 | -0.57 | -60.75% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
